Critical pathway improves arrival-in-cath-lab interval for patients with acute myocardial infarction in the emergency department

Japanese Circulation Journal

Volumn 65, Issue 10, 2001, Pages 849-852

  Nakamura, I ^a   Hori, S ^a   Suzuki, M ^a   Asakura, Y ^a   Yoshikawa, T ^a   Ogawa, S ^a   Aikawa, N ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Acute myocardial infarction; Arrival in cath lab interval; Clinical indicators; Critical pathway; Emergency department

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; FIRST AID; GENDER; HEALTH CARE QUALITY; HEART INFARCTION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; PATIENT TRANSPORT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; CHILD; CLINICAL PROTOCOL; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; INTENSIVE CARE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; STANDARD; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHILD; CLINICAL PROTOCOLS; COMPARATIVE STUDY; CRITICAL CARE; EMERGENCY MEDICAL SERVICES; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 0034767244     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.65.849     Document Type: Article

References (13)

1. Critical pathways as a strategy for improving care: Problems and potential
2. Critical pathways: A review
3. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
4. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
5. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function and survival after acute myocardial infarction
6. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction)
7. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
8. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
9. Time as an adjunctive agent to thrombolytic therapy
10. The effect of reduction of door-to-needle times on the administration of thrombolytic therapy for acute myocardial infarction
11. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. Part 7: The Era of repeffusion: Section 1: Acute coronary syndromes (acute myocardial infarction)
12. Effect of continuous quality improvement methods on reducing triage to thrombolytic interval for acute myocardial infarction
13. Reducing door-to-needle time: Treatment delay versus presentation delay